The determinants of very severe immune-related adverse events associated with immune checkpoint inhibitors: A prospective study of the French REISAMIC registry

Immune-related adverse events (irAEs) remain generally unpredictable, and severe irAEs remain challenging to detect early and manage. Very severe (grade IV–V) irAEs have not been extensively characterised in prospective studies, and their predictive factors remain unknown.

Lascia un commento